The Effects of Prolonged Head-Down Tilt Lithotomy Position on Lower Limb Haemodynamics (HELP)

April 27, 2026 updated by: Maria Perissiou, University of Portsmouth

The Effects of Prolonged Head-Down Tilt Lithotomy Position on Lower Limb Haemodynamics in Adults Undergoing Minimally Invasive Abdominopelvic Surgery: An Intraoperative Observational Study

During certain bowel surgeries for cancer (colorectal surgery), individuals frequently have to be placed in a head-down position to enable surgeons have optimal access to the cancer site. This position usually also involves bending the hips and knees while supporting the legs in stirrups. However, lying in this position for long periods of time can lower the flow of blood to the legs, which can potentially cause injury. This rare but severe consequence is called Well-Leg Compartment Syndrome (WLCS). If WLCS is not diagnosed quickly, it can lead to other difficult complications and a significant delay in recovery. Unfortunately, because the individual is under anaesthesia, diagnosis is delayed in many cases. There is very little information in the medical literature about how this damage to the legs progresses over the course of the surgery. To better understand how WLCS, how well blood vessels work during surgery will be assessed. The flow of blood and oxygen in the calf muscle will be assessed in 25 individuals placed in a head-down position during colorectal surgery. Likewise, blood samples will be obtained in order to measure the biological markers that may contribute to the development of WLCS.

Study Overview

Detailed Description

The development of lower limb compartment syndrome in the absence of trauma (known as well-leg compartment syndrome, WLCS) is a severe complication reported during prolonged pelvic surgery. WLCS is characterised by muscular ischaemia and secondary necrosis from the increase in hydrostatic pressure in a closed fascial compartment.

The aetiology of WLCS appears to be primarily related to ischaemia of the lower limbs after a prolonged period in the head-down tilt lithotomy (HDTL) position, which is commonly used to access the pelvis and perineum during urological, colorectal, and gynaecological surgery. Elevation of the lower limbs above the heart results in a ~2 mmHg drop in mean arterial pressure at the mid-calf for every 2.5 cm that the limbs are raised. These hemodynamic changes are accompanied by an increase in compartment pressures associated with limb elevation and are further exacerbated by a steep (>15°) head-down tilt. The outcome of these changes ultimately leads to the development of significant and (often unrecognised) intraoperative ischemia in the lower limbs.

Prolonged reductions in lower limb perfusion during HDTL can cause the development of localised tissue oedema, leading to marked intracompartmental hypertension, which is further exacerbated once the limbs are lowered and reperfusion of ischemic muscle occurs. This is a consequence known as ischaemic-reperfusion injury (IRI), a phenomenon where reperfusion per se may result in a local and systemic inflammatory response that may augment tissue injury in excess of that produced by ischaemia alone.

Microvascular injury is considered one of the major determinants of IRI, particularly due to increased permeability of capillaries and arterioles that lead to an increase in diffusion and fluid filtration across the tissues. Subsequently, activated endothelial cells produce more reactive oxygen species and less nitric oxide, and this imbalance results in a corresponding inflammatory response and increased oxidative stress, which if sufficiently severe lead to further lower limb muscle and nerve injury.

The incidence of WLCS is unpredictable and as the individual is anaesthetised, the diagnosis is delayed in many cases, so the residual motor-sensory deficit may be severe, even after fasciotomy. Although there are many published case reports of this condition, it is likely that many cases of WLCS go unreported, and some may be mild and escape clinical detection. However, in cases that have been reported, the incidence of permanent disability after the development of WLCS ranges from ≈30% to ≈100%.

The paucity of detailed observational studies into the effects of HDTL on lower limb haemodynamics and tissue oxygenation has restricted the ability of the clinical and scientific society to construct clinical strategies to minimise this complication. Identifying individuals with risk factors and increasing surveillance during surgery in these people may allow for early detection and decrease the morbidity and potential mortality associated with intraoperative WLCS.

The study aims to assess lower limb haemodynamics by measuring cutaneous blood flow, muscle and brain tissue oxygenation, inflammatory and oxidative stress biomarkers during pelvic surgery in patients placed in HDTL. This study has the potential to provide a better understanding of the pathogenesis of WLCS and add novel knowledge regarding its early diagnosis.

Study Type

Observational

Enrollment (Actual)

26

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Sussex
      • Portsmouth, West Sussex, United Kingdom, PO6 3LY
        • Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult individuals(18 years and above) scheduled to undergo surgery in the HDTL position at the Department of Colorectal Surgery, Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust.

Description

Inclusion Criteria:

  • Adults scheduled to undergo colorectal surgery in the HDTL position

Exclusion Criteria:

  • History of myocardial infarction or cerebro-vascular events in the last 12 months
  • Previous revascularisation procedure in their lower limbs
  • BMI > 40 kg/m2
  • Inability to give informed consent
  • Other serious medical conditions, which in the opinion of study investigators, would interfere with safety or data interpretation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Colorectal surgery
Individuals scheduled for colorectal surgery in the HDTL position
All participants will undergo NIRS monitoring of muscle and cerebral tissue oxygenation intraoperatively.
Cutaneous blood flow will be assessed intraoperatively via Laser Doppler flowmetry in all participants
Blood samples will be taken to measure biomarkers of inflammation and oxidative stress at specific time points

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cutaneous blood flow
Time Frame: baseline, during the surgery
Change over time in cutaneous blood flow in the legs relative to a vascular occlusion test (VOT) during surgery in the HDTL position.
baseline, during the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle tissue oxygenation
Time Frame: baseline, during the surgery
Change over time in muscle tissue oxygenation in the lower limb relative to a vascular occlusion test (VOT) during surgery in the HDTL position.
baseline, during the surgery
Plasma interleukin-6 (IL-6) concentration
Time Frame: baseline, during the surgery
Change over time in [IL-6] during surgery in the HDTL position.
baseline, during the surgery
Plasma Tumour Necrosis Factor Alpha (TNF-α) concentration
Time Frame: baseline, during the surgery
Change over time in [TNF-α] during surgery in the HDTL position.
baseline, during the surgery
Plasma Superoxide Dismutase (SOD) concentration
Time Frame: baseline, during the surgery
Change over time in [SOD] during surgery in the HDTL position.
baseline, during the surgery
Plasma Protein Carbonyl concentration
Time Frame: baseline, during the surgery
Change over time in [protein carbonyl] during surgery in the HDTL position.
baseline, during the surgery
Plasma nitrate concentration
Time Frame: baseline, during the surgery
Change over time in [nitrate] during surgery in the HDTL position.
baseline, during the surgery
Plasma nitrite concentration
Time Frame: baseline, during the surgery
Change over time in [nitrite] during surgery in the HDTL position.
baseline, during the surgery
Mean arterial pressure (MAP)
Time Frame: baseline, during the surgery
Change over time in MAP during surgery in the HDTL position.
baseline, during the surgery
Skin temperature
Time Frame: baseline, during the surgery
Change over time in skin temperature during surgery in the HDTL position.
baseline, during the surgery
Brain tissue oxygenation
Time Frame: continuous measurement during the surgery
Change over time in brain tissue oxygenation during surgery in the HDTL position.
continuous measurement during the surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chukwuemeka C Uzoma, MBBS, University of Portsmouth
  • Principal Investigator: Maria C Perissiou, PhD, University of Portsmouth

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2024

Primary Completion (Actual)

November 3, 2025

Study Completion (Actual)

November 3, 2025

Study Registration Dates

First Submitted

September 3, 2023

First Submitted That Met QC Criteria

September 11, 2023

First Posted (Actual)

September 14, 2023

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Compartment Syndrome Nontraumatic Lower Extremity

Clinical Trials on NIRS monitoring

Subscribe